[{"nct_id":"NCT01446965","url":"https://clinicaltrials.gov/show/NCT01446965","official_title":"Prevention of Sudden Death After Myocardial Infarction Using a LifeVest Wearable Cardioverter-defibrillator"},{"nct_id":"NCT02448550","url":"https://clinicaltrials.gov/show/NCT02448550","official_title":"Comparison of Unfractionated Heparin and Bivalirudin for Percutaneous Coronary Intervention for Stable Angina, Unstable Angina, and Non-ST Segment Elevation Myocardial Infarction"},{"nct_id":"NCT01875835","url":"https://clinicaltrials.gov/show/NCT01875835","official_title":"Evaluation of Neointimal Coverage of Everolimus-Eluting Stent and Bare-metal Stent After Implantation in STEMI Patients by Optical Coherence Tomography"},{"nct_id":"NCT00597922","url":"https://clinicaltrials.gov/show/NCT00597922","official_title":"Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction (AMI) Patients (VIRGO)"},{"nct_id":"NCT00285922","url":"https://clinicaltrials.gov/show/NCT00285922","official_title":"Comparison of Estimated Body Surface Potential Mapping With Standard Electrocardiography in Patients Presenting to the Emergency Department With Chest Pain"},{"nct_id":"NCT00075088","url":"https://clinicaltrials.gov/show/NCT00075088","official_title":"Tele-electrocardiography in Emergency Cardiac Care"},{"nct_id":"NCT00091949","url":"https://clinicaltrials.gov/show/NCT00091949","official_title":"Insulin Resistance Intervention After Stroke (IRIS) Trial"},{"nct_id":"NCT00952744","url":"https://clinicaltrials.gov/show/NCT00952744","official_title":"Copeptin Helps in the Early Detection Of Patients With Acute Myocardial"},{"nct_id":"NCT01755052","url":"https://clinicaltrials.gov/show/NCT01755052","official_title":"SILVER-AMI: Risk Stratification in Older Persons With Acute Myocardial Infarction"},{"nct_id":"NCT01156662","url":"https://clinicaltrials.gov/show/NCT01156662","official_title":"Efficacy of Thrombosuction in Primary Percutaneous Coronary Intervention of Acute Myocardial Infarction"},{"nct_id":"NCT00877903","url":"https://clinicaltrials.gov/show/NCT00877903","official_title":"A Phase II, Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Efficacy of PROCHYMALÂ® (Ex Vivo Cultured Adult Human Mesenchymal Stem Cells) Intravenous Infusion Following Acute Myocardial Infarction"},{"nct_id":"NCT00112281","url":"https://clinicaltrials.gov/show/NCT00112281","official_title":"A Phase III International, Multi-Center, Prospective, Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of Nitric Oxide Synthase Inhibition With Tilarginine Acetate Injection in Patients With Cardiogenic Shock Complicating Acute Myocardial Infarction, or the TRIUMPH Trial"},{"nct_id":"NCT00781118","url":"https://clinicaltrials.gov/show/NCT00781118","official_title":"AngelMed for Early Recognition and Treatment of STEMI"},{"nct_id":"NCT01495364","url":"https://clinicaltrials.gov/show/NCT01495364","official_title":"A Prospective Randomized Double Blind Placebo Controlled Phase II Trial of Intra-coronary Infusion of AMR-001, a Bone Marrow Derived Autologous CD34+ Selected Cell Product, in Patients With Acute Myocardial Infarction."},{"nct_id":"NCT00114452","url":"https://clinicaltrials.gov/show/NCT00114452","official_title":"A Phase 1 Randomized, Double-blind, Placebo-controlled, Dose Escalation, Multicenter Study to Determine the Safety of Intravenous Ex-vivo Cultured Adult Human Mesenchymal Stem Cells (Provacel) Following Acute Myocardial Infarction"},{"nct_id":"NCT00004732","url":"https://clinicaltrials.gov/show/NCT00004732","official_title":"Carotid Revascularization Endarterectomy Versus Stenting Trial (CREST)"},{"nct_id":"NCT00977938","url":"https://clinicaltrials.gov/show/NCT00977938","official_title":"A Prospective, Multi-center, Randomized, Double-blind Trial to Assess the Effectiveness and Safety of 12 Versus 30 Months of Dual Antiplatelet Therapy in Subjects Undergoing Percutaneous Coronary Intervention With Either Drug-eluting Stent or Bare Metal Stent Placement for the Treatment of Coronary Artery Lesions"},{"nct_id":"NCT02481544","url":"https://clinicaltrials.gov/show/NCT02481544","official_title":"The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients"},{"nct_id":"NCT00303979","url":"https://clinicaltrials.gov/show/NCT00303979","official_title":"Registry to Improve the Use of Evidence-Based Heart Failure Therapies in the Outpatient Setting"},{"nct_id":"NCT00319566","url":"https://clinicaltrials.gov/show/NCT00319566","official_title":"Heart and Estrogen-Progestin Replacement Study (HERS)"},{"nct_id":"NCT00691470","url":"https://clinicaltrials.gov/show/NCT00691470","official_title":"A Randomized, Double Blind Comparison of ATI-5923, a Novel Vitamin K Antagonist, With Warfarin in Patients Requiring Chronic Anticoagulation"},{"nct_id":"NCT01471522","url":"https://clinicaltrials.gov/show/NCT01471522","official_title":"International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)"},{"nct_id":"NCT00831441","url":"https://clinicaltrials.gov/show/NCT00831441","official_title":"Apixaban for Prevention of Acute Ischemic Events - 2 A Phase 3, Randomized, Double-Blind, Evaluation of the Safety and Efficacy of Apixaban In Subjects With a Recent Acute Coronary Syndrome"},{"nct_id":"NCT00831116","url":"https://clinicaltrials.gov/show/NCT00831116","official_title":"Chemometric Observation of Lipid Core Plaques of Interest in Native Coronary Arteries Registry"},{"nct_id":"NCT00880802","url":"https://clinicaltrials.gov/show/NCT00880802","official_title":"Finding ACS With Serial Troponin Testing for Rapid Assessment of Cardiac Ischemic Symptoms"},{"nct_id":"NCT00017953","url":"https://clinicaltrials.gov/show/NCT00017953","official_title":"Look AHEAD: Action for Health in Diabetes"},{"nct_id":"NCT00321399","url":"https://clinicaltrials.gov/show/NCT00321399","official_title":"SPARC, Including Its Pilot CT Angiographic Study, is a Prospective, Open-label, Multicenter, Sequentially Sampled, Observational Registry to Define the Clinical Value of Stress Perfusion (Stress SPECT, Stress PET), Noninvasive Angiography (CTA) and Combined Perfusion-anatomy (PET/CT) Studies in Patients With Known or Suspected CAD With Respect to Post-test Resource Utilization and Prediction of Cardiac Death and Non-fatal Myocardial Infarction"},{"nct_id":"NCT00991029","url":"https://clinicaltrials.gov/show/NCT00991029","official_title":"Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial"},{"nct_id":"NCT00833612","url":"https://clinicaltrials.gov/show/NCT00833612","official_title":"A Multi-center, Randomized, Controlled Study of Mechanical Left Ventricular Unloading With Counterpulsation to Reduce Infarct Size Pre-PCI for Acute Myocardial Infarction - CRISP AMI"},{"nct_id":"NCT00048308","url":"https://clinicaltrials.gov/show/NCT00048308"},{"nct_id":"NCT01594333","url":"https://clinicaltrials.gov/show/NCT01594333","official_title":"A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome"},{"nct_id":"NCT01225562","url":"https://clinicaltrials.gov/show/NCT01225562","official_title":"A Randomized, Double-Blind, Placebo Controlled, Parallel Group, Multinational Trial, to Assess the Prevention of Thrombotic Events With Ticagrelor Compared to Placebo on a Background of Acetyl Salicylic Acid (ASA) Therapy in Patients With History of Myocardial Infarction"},{"nct_id":"NCT02425345","url":"https://clinicaltrials.gov/show/NCT02425345","official_title":"Women's Health Initiative Strong and Healthy Study"},{"nct_id":"NCT01171404","url":"https://clinicaltrials.gov/show/NCT01171404","official_title":"Long-term Follow-up of Antithrombotic Management Patterns in Acute Coronary Syndrome Patients"},{"nct_id":"NCT01076764","url":"https://clinicaltrials.gov/show/NCT01076764","official_title":"Randomized, Double-blind, Triple-dummy Trial to Compare the Efficacy of Otamixaban With Unfractionated Heparin + Eptifibatide, in Patients With Unstable Angina/Non ST Segment Elevation Myocardial Infarction Scheduled to Undergo an Early Invasive Strategy"},{"nct_id":"NCT01877941","url":"https://clinicaltrials.gov/show/NCT01877941","official_title":"Clinical Evaluation of Cardiac Output Estimation Based on Pulse Wave Transit Time"},{"nct_id":"NCT01975389","url":"https://clinicaltrials.gov/show/NCT01975389","official_title":"Phase 3 Multi Center, Double Blind, Randomized, Placebo Controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (Pf-04950615), In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects"},{"nct_id":"NCT01975376","url":"https://clinicaltrials.gov/show/NCT01975376","official_title":"Phase 3 Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel Group Evaluation Of The Efficacy, Safety, And Tolerability Of Bococizumab (PF-04950615) In Reducing The Occurrence Of Major Cardiovascular Events In High Risk Subjects."},{"nct_id":"NCT01877915","url":"https://clinicaltrials.gov/show/NCT01877915","official_title":"A Randomized, Double-blind, Event-driven, Multicenter Study Comparing the Efficacy and Safety of Rivaroxaban With Placebo for Reducing the Risk of Death, Myocardial Infarction or Stroke in Subjects With Heart Failure and Significant Coronary Artery Disease Following an Episode of Decompensated Heart Failure"},{"nct_id":"NCT00000492","url":"https://clinicaltrials.gov/show/NCT00000492"},{"nct_id":"NCT00734760","url":"https://clinicaltrials.gov/show/NCT00734760","official_title":"Reducing Prehospital Delay in Acute Myocardial Infarction"},{"nct_id":"NCT00809965","url":"https://clinicaltrials.gov/show/NCT00809965","official_title":"A Randomized, Double-Blind, Placebo-Controlled, Event-Driven Multicenter Study to Evaluate the Efficacy and Safety of Rivaroxaban in Subjects With a Recent Acute Coronary Syndrome"},{"nct_id":"NCT00968708","url":"https://clinicaltrials.gov/show/NCT00968708","official_title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment With Alogliptin in Addition to Standard of Care in Subjects With Type 2 Diabetes and Acute Coronary Syndrome"},{"nct_id":"NCT00430612","url":"https://clinicaltrials.gov/show/NCT00430612","official_title":"The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)"},{"nct_id":"NCT02108262","url":"https://clinicaltrials.gov/show/NCT02108262","official_title":"A Phase 2b, Multi-center, Randomized, Placebo-controlled, Dose-ranging Study to Investigate the Safety and Tolerability of Multiple Dose Administration of CSL112 in Subjects With Acute Myocardial Infarction."},{"nct_id":"NCT00785954","url":"https://clinicaltrials.gov/show/NCT00785954","official_title":"Inhibition of Delta-protein Kinase C for the Reduction of Infarct Size in Acute Myocardial Infarction"},{"nct_id":"NCT00046228","url":"https://clinicaltrials.gov/show/NCT00046228","official_title":"A Muticenter, Randomized, Double-blind, Placebo Controlled Trial Comparing the Efficacy and Safety of Reteplease and Abciximab Combination Therapy With Abciximab Alone Administered Early or Just Prior to Primary Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction."},{"nct_id":"NCT01776424","url":"https://clinicaltrials.gov/show/NCT01776424","official_title":"A Randomized Controlled Trial of Rivaroxaban for the Prevention of Major Cardiovascular Events in Patients With Coronary or Peripheral Artery Disease (COMPASS - Cardiovascular OutcoMes for People Using Anticoagulation StrategieS)"},{"nct_id":"NCT00931502","url":"https://clinicaltrials.gov/show/NCT00931502","official_title":"Contemporary Treatment Of Stent Thrombosis In Acute Coronary Syndromes"},{"nct_id":"NCT02406677","url":"https://clinicaltrials.gov/show/NCT02406677","official_title":"Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study"},{"nct_id":"NCT02271022","url":"https://clinicaltrials.gov/show/NCT02271022","official_title":"Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry"},{"nct_id":"NCT00823212","url":"https://clinicaltrials.gov/show/NCT00823212","official_title":"PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Elementâ¢) for the Treatment of up to Two De Novo Coronary Artery Lesions"},{"nct_id":"NCT00091637","url":"https://clinicaltrials.gov/show/NCT00091637","official_title":"APEX-AMI - Pexelizumab in Conjunction With Angioplasty"},{"nct_id":"NCT00000491","url":"https://clinicaltrials.gov/show/NCT00000491"},{"nct_id":"NCT01458405","url":"https://clinicaltrials.gov/show/NCT01458405","official_title":"Randomized, Double-Blind, Placebo-Controlled Phase I/II Study of the Safety and Efficacy of Intracoronary Delivery of Allogeneic Cardiosphere-Derived Cells in Patients With a Myocardial Infarction and Ischemic Left Ventricular Dysfunction"},{"nct_id":"NCT00526253","url":"https://clinicaltrials.gov/show/NCT00526253","official_title":"A Multicenter Study to Assess the Safety and Cardiovascular Effects of Myocellâ¢ Implantation by a Catheter Delivery System in Congestive Heart Failure Patients Post Myocardial Infarction(s)"},{"nct_id":"NCT00391872","url":"https://clinicaltrials.gov/show/NCT00391872","official_title":"A Randomised, Double-blind, Parallel Group, Phase 3, Efficacy and Safety Study of Ticagrelor Compared With Clopidogrel for Prevention of Vascular Events in Patients With Non-ST or ST Elevation Acute Coronary Syndromes (ACS) [PLATO- a Study of PLATelet Inhibition and Patient Outcomes]"},{"nct_id":"NCT01866904","url":"https://clinicaltrials.gov/show/NCT01866904","official_title":"TIGRIS: Long-Term rIsk, Clinical manaGement and Healthcare Resource Utilization of Stable Coronary Artery dISease in Post Myocardial Infarction Patients"},{"nct_id":"NCT01327183","url":"https://clinicaltrials.gov/show/NCT01327183","official_title":"A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY EVALUATING THE EFFICACY AND SAFETY OF 2 DOSES OF RO4905417 (R1512) ADMINISTERED TO PATIENTS WITH NON ST-ELEVATION MYOCARDIAL INFARCTION (NON-STEMI) UNDERGOING PERCUTANEOUS CORONARY INTERVENTION (PCI)"},{"nct_id":"NCT00557921","url":"https://clinicaltrials.gov/show/NCT00557921","official_title":"A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease"},{"nct_id":"NCT01431105","url":"https://clinicaltrials.gov/show/NCT01431105","official_title":"Phase I/IIa Study of Pharmacokinetics and Safety of Atorvastatin in Children With Coronary Artery Abnormalities Secondary to Kawasaki Disease"},{"nct_id":"NCT00153101","url":"https://clinicaltrials.gov/show/NCT00153101","official_title":"ONTARGET ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial A Large, Simple Randomized Trial of an Angiotensin II Receptor Antagonist (Telmisartan) and an ACE-Inhibitor (Ramipril) in Patients at High Risk for Cardiovascular Events and TRANSCEND Telmisartan Randomized AssessmeNt Study in aCE iNtolerant Subjects With Cardiovascular Disease. A Parallel Study Comparing the Effects of Telmisartan With Placebo and Outcomes in Patients at High Risk for Cardiovascular Events and Intolerant to ACE-I."},{"nct_id":"NCT02576288","url":"https://clinicaltrials.gov/show/NCT02576288","official_title":"Effects of Sitagliptin on Arterial Vasoreactivity and Proatherogenic Mediators in Obesity"},{"nct_id":"NCT02094755","url":"https://clinicaltrials.gov/show/NCT02094755","official_title":"Prevalence of High On-Treatment (Aspirin and Clopidogrel) Platelet Reactivity in Patients With Critical Limb Ischemia"},{"nct_id":"NCT01000727","url":"https://clinicaltrials.gov/show/NCT01000727","official_title":"A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects Following Acute Coronary Syndrome to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)."},{"nct_id":"NCT01101035","url":"https://clinicaltrials.gov/show/NCT01101035","official_title":"A Multicenter, Randomized, Active-Control, Phase 3B Study to Evaluate the Cardiovascular Safety of Febuxostat and Allopurinol in Subjects With Gout and Cardiovascular Comorbidities"},{"nct_id":"NCT01732822","url":"https://clinicaltrials.gov/show/NCT01732822","official_title":"A Randomized, Double-blind, Parallel Group, Multicentre Phase IIIb Study to Compare Ticagrelor With Clopidogrel Treatment on the Risk of Cardiovascular Death, Myocardial Infarction and Ischemic Stroke in Patients With Established Peripheral Artery Disease (EUCLID Examining Use of tiCagreLor In paD)"},{"nct_id":"NCT01931956","url":"https://clinicaltrials.gov/show/NCT01931956","official_title":"A Continued Access Registry of the EvalveÂ® MitraClipÂ® System: EVEREST II Real World Expanded Multicenter Study of the MitraClip System (REALISM)"},{"nct_id":"NCT00699998","url":"https://clinicaltrials.gov/show/NCT00699998","official_title":"A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects With Unstable Angina/Non-ST-Elevation Myocardial Infarction Who Are Medically Managed"},{"nct_id":"NCT00799903","url":"https://clinicaltrials.gov/show/NCT00799903","official_title":"LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)"},{"nct_id":"NCT01665053","url":"https://clinicaltrials.gov/show/NCT01665053","official_title":"EVOLVE II: A Prospective Multicenter Trial to Assess the Safety and Effectiveness of the SYNERGY Everolimus-Eluting Platinum Chromium Coronary Stent System (SYNERGY Stent System) for the Treatment of Atherosclerotic Lesion(s)"},{"nct_id":"NCT00341614","url":"https://clinicaltrials.gov/show/NCT00341614","official_title":"The Effects of an Exercise and Diet Intervention on Cardiovascular Risk Factors in Postmenopausal Type 2 Diabetics"},{"nct_id":"NCT00874354","url":"https://clinicaltrials.gov/show/NCT00874354","official_title":"REVITALIZE: Randomized Evaluation of Intracoronary Transplantation of Bone Marrow Stem Cells in Myocardial Infarction"},{"nct_id":"NCT00067236","url":"https://clinicaltrials.gov/show/NCT00067236","official_title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral PG-116800 Following a Heart Attack"},{"nct_id":"NCT00412984","url":"https://clinicaltrials.gov/show/NCT00412984","official_title":"A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects With Nonvalvular Atrial Fibrillation"},{"nct_id":"NCT02099903","url":"https://clinicaltrials.gov/show/NCT02099903","official_title":"Transcatheter Renal Denervation in Patients With Systolic Heart Failure Due to Chagas' Disease - a Safety and Efficacy Study."},{"nct_id":"NCT00047437","url":"https://clinicaltrials.gov/show/NCT00047437","official_title":"Heart Failure: A Controlled Trial Investigating Outcomes of Exercise Training (HF-ACTION)"},{"nct_id":"NCT00041938","url":"https://clinicaltrials.gov/show/NCT00041938","official_title":"Warfarin Versus Aspirin in Reduced Cardiac Ejection Fraction (WARCEF) Trial"},{"nct_id":"NCT01327846","url":"https://clinicaltrials.gov/show/NCT01327846","official_title":"A Randomized, Double-blind, Placebo-controlled, Event Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post-Myocardial Infarction Patients With Elevated hsCRP Including Substudies to Evaluate the Effect of Canakinumab on Carotid Atherosclerosis, and on Glucose Control Following OGTT in T2DM"},{"nct_id":"NCT02115230","url":"https://clinicaltrials.gov/show/NCT02115230","official_title":"Transcatheter Renal Denervation in Heart Failure With Normal Left Ventricular Ejection Fraction - a Safety and Efficacy Study of Irrigated Radiofrequency Catheter"},{"nct_id":"NCT02255123","url":"https://clinicaltrials.gov/show/NCT02255123","official_title":"A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)"},{"nct_id":"NCT00893360","url":"https://clinicaltrials.gov/show/NCT00893360","official_title":"A Phase I Randomized, Dose Escalation Study of the Safety and Efficacy of Intracoronary Delivery of Cardiosphere-Derived Stem Cells in Patients With Ischemic Left Ventricular Dysfunction and a Recent Myocardial Infarction"},{"nct_id":"NCT01764633","url":"https://clinicaltrials.gov/show/NCT01764633","official_title":"A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing the Impact of Additional LDL-Cholesterol Reduction on Major Cardiovascular Events When Evolocumab (AMG 145) is Used in Combination With Statin Therapy In Patients With Clinically Evident Cardiovascular Disease"},{"nct_id":"NCT02297737","url":"https://clinicaltrials.gov/show/NCT02297737","official_title":"Developing a Mindfulness Movement Intervention Program for Post-MI Patients: A Randomized 75-subject Pilot Clinical Trial of Tai Chi Versus Health Education in Post-myocardial Infarction Patients"},{"nct_id":"NCT01005485","url":"https://clinicaltrials.gov/show/NCT01005485","official_title":"Comprehensive Molecular and Morphologic Characterization of Circulating Endothelial Cells"},{"nct_id":"NCT00908856","url":"https://clinicaltrials.gov/show/NCT00908856","official_title":"Safety of IV Autologous Mononuclear Cells and Marrow Stromal Cells After Stroke"},{"nct_id":"NCT01213251","url":"https://clinicaltrials.gov/show/NCT01213251","official_title":"Post-Myocardial Infarction Remodeling Prevention Therapy"},{"nct_id":"NCT02155985","url":"https://clinicaltrials.gov/show/NCT02155985","official_title":"Modulation of Immune Activation by Aspirin"},{"nct_id":"NCT02293395","url":"https://clinicaltrials.gov/show/NCT02293395","official_title":"A Randomized, Double-Blind, Double-Dummy, Active-controlled, Parallel-group, Multicenter Study to Compare the Safety of Rivaroxaban Versus Acetylsalicylic Acid in Addition to Either Clopidogrel or Ticagrelor Therapy in Subjects With Acute Coronary Syndrome"},{"nct_id":"NCT01226563","url":"https://clinicaltrials.gov/show/NCT01226563","official_title":"A Placebo Controlled , Multicenter, Randomized, Double Blind Trial to Evaluate the Safety and Effectiveness of IK-5001 for the Prevention of Remodeling of the Ventricle and Congestive Heart Failure After Acute Myocardial Infarction - Preservation I Trial"},{"nct_id":"NCT00088179","url":"https://clinicaltrials.gov/show/NCT00088179","official_title":"A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study of Pexelizumab in Patients Undergoing Coronary Artery Bypass Grafting With Cardiopulmonary Bypass (PRIMO-CABG II)"},{"nct_id":"NCT01178320","url":"https://clinicaltrials.gov/show/NCT01178320","official_title":"Carotid Plaque Characteristics by MRI in AIM-HIGH"},{"nct_id":"NCT00997503","url":"https://clinicaltrials.gov/show/NCT00997503","official_title":"TAXUS LibertÄ Post Approval Study: A U.S. Post-Approval Study of the TAXUSÂ® LibertÃ©Â® Paclitaxel-Eluting Coronary Stent System"},{"nct_id":"NCT01268319","url":"https://clinicaltrials.gov/show/NCT01268319","official_title":"A Randomized Pilot Trial of the Use of a Distal Protection Device to Prevent Peri-procedural MI During Dilation of Coronary Stenoses Caused by Plaques With Large Lipid Cores"},{"nct_id":"NCT01732341","url":"https://clinicaltrials.gov/show/NCT01732341","official_title":"APPOSITION V: Stentys Coronary Stent System Clinical Trial in Patients With Acute Myocardial Infarction"},{"nct_id":"NCT00496769","url":"https://clinicaltrials.gov/show/NCT00496769","official_title":"Apixaban Versus Acetylsalicylic Acid (ASA) to Prevent Stroke in Atrial Fibrillation Patients Who Have Failed or Are Unsuitable for Vitamin K Antagonist Treatment: A Randomized Double-blind Trial"},{"nct_id":"NCT01149044","url":"https://clinicaltrials.gov/show/NCT01149044","official_title":"TOTAL Trial: A Randomized Trial of Routine Aspiration ThrOmbecTomy With PCI Versus PCI ALone in Patients With STEMI Undergoing Primary PCI"},{"nct_id":"NCT00910962","url":"https://clinicaltrials.gov/show/NCT00910962","official_title":"A Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety of 12 Weeks of Dosing With GW856553 and Its Effects on Inflammatory Markers, Infarct Size, and Cardiac Function in Subjects With Myocardial Infarction Without ST-segment Elevation"},{"nct_id":"NCT02145468","url":"https://clinicaltrials.gov/show/NCT02145468","official_title":"A Clinical Outcomes Study to Compare the Incidence of Major Adverse Cardiovascular Events in Subjects Presenting With Acute Coronary Syndrome Treated With Losmapimod Compared to Placebo (PM1116197) LosmApimod To Inhibit p38 MAP Kinase as a TherapeUtic Target and moDify Outcomes After an Acute Coronary syndromE (LATITUDE)-TIMI 60."},{"nct_id":"NCT01730534","url":"https://clinicaltrials.gov/show/NCT01730534","official_title":"Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes"},{"nct_id":"NCT01107886","url":"https://clinicaltrials.gov/show/NCT01107886","official_title":"A Multicentre, Randomised, Double-Blind, Placebo-Controlled Phase IV Trial to Evaluate the Effect of Saxagliptin on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischaemic Stroke in Patients With Type 2 Diabetes"},{"nct_id":"NCT02164864","url":"https://clinicaltrials.gov/show/NCT02164864","official_title":"A Prospective Randomised, Open Label, Blinded Endpoint (PROBE) Study to Evaluate DUAL Antithrombotic Therapy With Dabigatran Etexilate (110mg and 150mg b.i.d.) Plus Clopidogrel or Ticagrelor vs. Triple Therapy Strategy With Warfarin (INR 2.0 - 3.0) Plus Clopidogrel or Ticagrelor and Aspirin in Patients With Non Valvular Atrial Fibrillation (NVAF) That Have Undergone a Percutaneous Coronary Intervention (PCI) With Stenting"},{"nct_id":"NCT00365794","url":"https://clinicaltrials.gov/show/NCT00365794"},{"nct_id":"NCT02407002","url":"https://clinicaltrials.gov/show/NCT02407002","official_title":"The Use of Nitroglycerin by Paramedics for Treatment of Acute ST-elevation Myocardial Infarction (STEMI) in the Field"},{"nct_id":"NCT00126750","url":"https://clinicaltrials.gov/show/NCT00126750","official_title":"MI-Plus: Web-enhanced Guideline Implementation for Post MI CBOC Patients"},{"nct_id":"NCT00346216","url":"https://clinicaltrials.gov/show/NCT00346216","official_title":"A Randomized, Double Blind, Parallel-group Study Of Cardiovascular Safety In Osteoarthritis Or Rheumatoid Arthritis Patients With Or At High Risk For Cardiovascular Disease Comparing Celecoxib With Naproxen And Ibuprofen"},{"nct_id":"NCT02504216","url":"https://clinicaltrials.gov/show/NCT02504216","official_title":"An International, Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Trial Investigating the Efficacy and Safety of Rivaroxaban to Reduce the Risk of Major Thrombotic Vascular Events in Patients With Symptomatic Peripheral Artery Disease Undergoing Lower Extremity Revascularization Procedures"},{"nct_id":"NCT01969240","url":"https://clinicaltrials.gov/show/NCT01969240","official_title":"Shared Decision Making in the Emergency Department: The Chest Pain Choice Trial"},{"nct_id":"NCT01733901","url":"https://clinicaltrials.gov/show/NCT01733901","official_title":"Safety and Effectiveness Study of Percutaneous Catheter-based Renal Sympathetic Denervation as a Method of Secondary Prevention for Patients After Percutaneous Coronary Intervention."},{"nct_id":"NCT02344290","url":"https://clinicaltrials.gov/show/NCT02344290","official_title":"Randomized Trial to Prevent Vascular Events in HIV - REPRIEVE"},{"nct_id":"NCT00310544","url":"https://clinicaltrials.gov/show/NCT00310544","official_title":"Multicenter, Single-blind, Randomized, Intraindividual Study of the Safety and Efficacy of Magnevist Gadopentetate Dimeglumine (MagnevistÂ® Injection) at 0.1 and 0.2 mmol/kg for the Depiction of Delayed Enhancement in Patients With Documented Myocardial Infarction"},{"nct_id":"NCT01519141","url":"https://clinicaltrials.gov/show/NCT01519141","official_title":"Immunologic and Inflammatory Factors and Cardiovascular Risk in Patients With HIV Infection or Autoimmune Diseases"},{"nct_id":"NCT00472095","url":"https://clinicaltrials.gov/show/NCT00472095","official_title":"Utility of a Diabetes Themed Fotonovela to Encourage Glycemic Control: a Culturally Appropriate Tool for Education in Latinos"},{"nct_id":"NCT00741091","url":"https://clinicaltrials.gov/show/NCT00741091","official_title":"A Carotid Stenting Boston Scientific Surveillance Program Carotid WALLSTENT Monorail Endoprosthesis FilterWire EZâ¢ Embolic Protection System"},{"nct_id":"NCT01894152","url":"https://clinicaltrials.gov/show/NCT01894152","official_title":"Evaluate the Continued Safety and Effectiveness of the XIENCE PRIME EECSS in a Cohort of Real-world Patients Receiving the XIENCE PRIME EECSS During Commercial Use."},{"nct_id":"NCT01674647","url":"https://clinicaltrials.gov/show/NCT01674647","official_title":"A Prospective, Randomized, Open-label, Parallel-group, Active-controlled, Multicenter Study Exploring the Efficacy and Safety of Once-daily Oral Rivaroxaban (BAY59-7939) Compared With That of Dose-adjusted Oral Vitamin K Antagonists (VKA) for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion"},{"nct_id":"NCT02198144","url":"https://clinicaltrials.gov/show/NCT02198144","official_title":"Barber-Based Intervention for Hypertension in Black Men: Follow-Up Evaluation"},{"nct_id":"NCT00082745","url":"https://clinicaltrials.gov/show/NCT00082745","official_title":"Key Adverse Events After Childhood Cancer"},{"nct_id":"NCT00361855","url":"https://clinicaltrials.gov/show/NCT00361855","official_title":"A Phase 1 Open Label Dose Escalation Study Evaluate The Safety Of a Single Escalating Dose Of NX-CP105 (Human Adult Bone Marrow Derived Somatic Cells [hABM-SC] Administered by Endomyocardial Injection To Cohorts Of Adults 30-60 Days Following Acute Myocardial Infarction"},{"nct_id":"NCT01443637","url":"https://clinicaltrials.gov/show/NCT01443637","official_title":"COronary CT Angiography Evaluation For Clinical Outcomes: An International Multicenter Registry"},{"nct_id":"NCT00304148","url":"https://clinicaltrials.gov/show/NCT00304148","official_title":"Prospective Cohort Study of Chronic Renal Insufficiency"},{"nct_id":"NCT02415400","url":"https://clinicaltrials.gov/show/NCT02415400","official_title":"An Open-label, 2 x 2 Factorial, Randomized Controlled, Clinical Trial to Evaluate the Safety of Apixaban vs. Vitamin K Antagonist and Aspirin vs. Aspirin Placebo in Patients With Atrial Fibrillation and Acute Coronary Syndrome or Percutaneous Coronary Intervention"},{"nct_id":"NCT00484315","url":"https://clinicaltrials.gov/show/NCT00484315","official_title":"A Prospective Evaluation in a Randomized Trial of the Safety and Efficacy of the Use of the TAXUS Element Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions"},{"nct_id":"NCT02465515","url":"https://clinicaltrials.gov/show/NCT02465515","official_title":"A Long Term, Randomised, Double Blind, Placebo-controlled Study to Determine the Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Patients With Type 2 Diabetes Mellitus (HARMONY Outcomes)"},{"nct_id":"NCT00894803","url":"https://clinicaltrials.gov/show/NCT00894803","official_title":"The \"Combined Approach to Lysis Utilizing Eptifibatide and Rt-PA in Acute Ischemic Stroke-Enhanced Regimen\" (CLEAR-ER Stroke Trial)"},{"nct_id":"NCT00643201","url":"https://clinicaltrials.gov/show/NCT00643201","official_title":"A Safety and Efficacy Trial Evaluating the Use of Apixaban in the Treatment of Symptomatic Deep Vein Thrombosis and Pulmonary Embolism"},{"nct_id":"NCT00305240","url":"https://clinicaltrials.gov/show/NCT00305240","official_title":"Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER I)"},{"nct_id":"NCT00305214","url":"https://clinicaltrials.gov/show/NCT00305214","official_title":"Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients (MASTER II)"},{"nct_id":"NCT00313300","url":"https://clinicaltrials.gov/show/NCT00313300","official_title":"A Phase 2, Placebo-Controlled, Randomized, Double Blind, Parallel Arm, Dose Ranging Study to Evaluate Safety and Efficacy of Apixaban in Patients With a Recent Acute Coronary Syndrome."},{"nct_id":"NCT01402453","url":"https://clinicaltrials.gov/show/NCT01402453","official_title":"Monetary Incentives and Intrinsic Motivation to Sustain Hypertension Control Pilot Study"},{"nct_id":"NCT01601704","url":"https://clinicaltrials.gov/show/NCT01601704","official_title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Assessing the Occurrence of Major Adverse Cardiovascular Events (MACE) in Overweight and Obese Subjects With Cardiovascular Risk Factors Receiving Naltrexone SR/Bupropion SR"},{"nct_id":"NCT00066898","url":"https://clinicaltrials.gov/show/NCT00066898","official_title":"âReduction of Vascular Inflammation and Coronary Atherosclerosis With AGI-1067, a V-Protectant, Reduces Cardiovascular Events in Patients With Coronary Artery Diseaseâ"},{"nct_id":"NCT00007683","url":"https://clinicaltrials.gov/show/NCT00007683","official_title":"CSP #442 - Warfarin and Antiplatelet Therapy Study in Patients With Congestive Heart Failure (WATCH)"},{"nct_id":"NCT00005275","url":"https://clinicaltrials.gov/show/NCT00005275","official_title":"The Sleep Heart Health Study (SHHS) Was a Multi-site Prospective Cohort Study to Investigate Obstructive Sleep Apnea (OSA) and Other Sleep-disordered Breathing (SDB) as Risk Factors for Cardiovascular Diseases and Hypertension"},{"nct_id":"NCT01709669","url":"https://clinicaltrials.gov/show/NCT01709669","official_title":"The Impact of Gratitude on Biology and Behavior in Persons With Heart Disease"},{"nct_id":"NCT02091921","url":"https://clinicaltrials.gov/show/NCT02091921","official_title":"Switch to Ticagrelor in Critical Limb Ischemia Anti-platelet Study"},{"nct_id":"NCT01574703","url":"https://clinicaltrials.gov/show/NCT01574703","official_title":"A Phase 4, Non-treatment Follow-up For Cardiac Assessments Following Use Of Smoking Cessation Treatments In Subjects With And Without A History Of Psychiatric Disorders"},{"nct_id":"NCT00044213","url":"https://clinicaltrials.gov/show/NCT00044213","official_title":"Trial to Assess Chelation Therapy (TACT)"},{"nct_id":"NCT01589978","url":"https://clinicaltrials.gov/show/NCT01589978","official_title":"A U.S. Post-Approval Study of the PROMUS Elementâ¢ Plus Everolimus-Eluting Platinum Chromium Coronary Stent System"},{"nct_id":"NCT01615094","url":"https://clinicaltrials.gov/show/NCT01615094","official_title":"BNP and Neuroimmune Characteristics of CHF and Depression (Competing Renewal)"},{"nct_id":"NCT00579306","url":"https://clinicaltrials.gov/show/NCT00579306","official_title":"Levels of Inflammatory Markers in the Treatment of Stroke"},{"nct_id":"NCT01655433","url":"https://clinicaltrials.gov/show/NCT01655433","official_title":"VELOCITY: Pilot Study to Evaluate Ultrafast Hypothermia Before Reperfusion in Patients With Acute ST-Elevation Myocardial Infarction"},{"nct_id":"NCT00206830","url":"https://clinicaltrials.gov/show/NCT00206830","official_title":"SHORTness of Breath In the Emergency Department (SHORTIE)"},{"nct_id":"NCT00120289","url":"https://clinicaltrials.gov/show/NCT00120289","official_title":"AIM HIGH: Niacin Plus Statin to Prevent Vascular Events"},{"nct_id":"NCT00326196","url":"https://clinicaltrials.gov/show/NCT00326196","official_title":"CSP #557 - Coronary Artery Revascularization in Diabetes (VA CARDS)"},{"nct_id":"NCT00100178","url":"https://clinicaltrials.gov/show/NCT00100178","official_title":"New Onset of Type 1 Diabetes Mycophenolate Mofetil-Daclizumab Clinical Trial (Preservation of Pancreatic Production of Insulin Through Immunosuppression-POPPII #1)"},{"nct_id":"NCT00232180","url":"https://clinicaltrials.gov/show/NCT00232180","official_title":"The Effect Of Eplerenone Versus Placebo On Cardiovascular Mortality And Heart Failure Hospitalization In Subjects With NYHA Class II Chronic Systolic Heart Failure"},{"nct_id":"NCT00593385","url":"https://clinicaltrials.gov/show/NCT00593385","official_title":"Atrium iCAST Iliac Stent Pivotal Study"},{"nct_id":"NCT02179853","url":"https://clinicaltrials.gov/show/NCT02179853","official_title":"Anakinra in Infants and Children With Coronary Artery Abnormalities in Acute Kawasaki Disease"},{"nct_id":"NCT00807040","url":"https://clinicaltrials.gov/show/NCT00807040","official_title":"Evaluation of Outcomes Following Mitral Valve Repair/Replacement in Severe Chronic Ischemic Mitral Regurgitation"},{"nct_id":"NCT02174731","url":"https://clinicaltrials.gov/show/NCT02174731","official_title":"A Phase 3, Multicenter, Randomized, Open-label, Active-Controlled Study of the Safety and Efficacy of Roxadustat in the Treatment of Anemia in Dialysis Patients"},{"nct_id":"NCT01897532","url":"https://clinicaltrials.gov/show/NCT01897532","official_title":"CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk"},{"nct_id":"NCT01394952","url":"https://clinicaltrials.gov/show/NCT01394952","official_title":"The Effect of Dulaglutide on Major Cardiovascular Events in Patients With Type 2 Diabetes: Researching Cardiovascular Events With a Weekly INcretin in Diabetes (REWIND)"},{"nct_id":"NCT01179048","url":"https://clinicaltrials.gov/show/NCT01179048","official_title":"A Long-term, Multi-centre, International, Randomised Double-blind, Placebo-controlled Trial to Determine Liraglutide Effects on Cardiovascular Events"},{"nct_id":"NCT01994408","url":"https://clinicaltrials.gov/show/NCT01994408","official_title":"Automatic Medication Increase Protocol in the Treatment of Elevated Blood Pressure"},{"nct_id":"NCT02174627","url":"https://clinicaltrials.gov/show/NCT02174627","official_title":"A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Roxadustat for the Treatment of Anemia in Chronic Kidney Disease Patients Not on Dialysis"},{"nct_id":"NCT01131676","url":"https://clinicaltrials.gov/show/NCT01131676","official_title":"A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk"},{"nct_id":"NCT02224755","url":"https://clinicaltrials.gov/show/NCT02224755","official_title":"Thoratec Corporation MOMENTUM 3, Multi-center Study of MagLev Technology in Patients Undergoing MCS Therapy With HeartMate 3â¢ IDE Clinical Study Protocol"},{"nct_id":"NCT01330654","url":"https://clinicaltrials.gov/show/NCT01330654","official_title":"Using Heart Rate Variability to Analyze the Effect of Beta Blockers on Intermediate Risk Patients Undergoing Laparoscopic Surgical Procedures"},{"nct_id":"NCT01106534","url":"https://clinicaltrials.gov/show/NCT01106534","official_title":"XIENCE VÂ® Everolimus Eluting Coronary Stent System USA Post- Approval Study (XIENCE VÂ® USA DAPT Cohort) (XVU-AV DAPT)"},{"nct_id":"NCT01546987","url":"https://clinicaltrials.gov/show/NCT01546987","official_title":"Phase III Trial of Dose Escalated Radiation Therapy and Standard Androgen Deprivation Therapy (ADT) With a GNRH Agonist vs. Dose Escalated Radiation Therapy and Enhanced ADT With a GNRH Agonist and TAK-700 For Men With High Risk Prostate Cancer"},{"nct_id":"NCT00715273","url":"https://clinicaltrials.gov/show/NCT00715273","official_title":"Carotid Plaque Composition by Magnetic Resonance Imaging During Lipid Lowering Therapy"},{"nct_id":"NCT01468701","url":"https://clinicaltrials.gov/show/NCT01468701","official_title":"GLORIA - AF: Global Registry on Long-Term Oral Anti-thrombotic Treatment In Patients With Atrial Fibrillation (Phase II/III)"},{"nct_id":"NCT02121158","url":"https://clinicaltrials.gov/show/NCT02121158","official_title":"CSP #592 - Efficacy and Safety of ICD Implantation in the Elderly"},{"nct_id":"NCT02191735","url":"https://clinicaltrials.gov/show/NCT02191735","official_title":"Performance Evaluation of the RAMPÂ® Cardiac Tests / RAMPÂ® 200 in a Point-Of-Care Setting (C-POC)"},{"nct_id":"NCT01347710","url":"https://clinicaltrials.gov/show/NCT01347710","official_title":"A Phase 3, Open Label, Multicenter Study for the Assessment of Myocardial Perfusion Using Positron Emission Tomography (PET) Imaging of Flurpiridaz F18 Injection in Patients With Suspected or Known Coronary Artery Disease (CAD)"},{"nct_id":"NCT01121224","url":"https://clinicaltrials.gov/show/NCT01121224","official_title":"CSP #571 - Drug-eluting Stents vs. Bare Metal Stents in Saphenous Vein Graft Angioplasty (DIVA)"},{"nct_id":"NCT00880178","url":"https://clinicaltrials.gov/show/NCT00880178","official_title":"Plaque Inflammation and Dysfunctional HDL in AIM-HIGH"},{"nct_id":"NCT02341664","url":"https://clinicaltrials.gov/show/NCT02341664","official_title":"Patient and Provider Assessment of Lipid Management Registry"},{"nct_id":"NCT00549757","url":"https://clinicaltrials.gov/show/NCT00549757","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Determine Whether, in Patients With Type 2 Diabetes at High Risk for Cardiovascular and Renal Events, Aliskiren, on Top of Conventional Treatment, Reduces Cardiovascular and Renal Morbidity and Mortality"},{"nct_id":"NCT02316886","url":"https://clinicaltrials.gov/show/NCT02316886","official_title":"The Preventive Implantation of Bioresorbable Vascular Scaffold on Functionally Insignificant Stenosis With Vulnerable Plaque Characteristics"},{"nct_id":"NCT01442038","url":"https://clinicaltrials.gov/show/NCT01442038","official_title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of the Effects of Ranolazine on Major Adverse Cardiovascular Events in Subjects With a History of Chronic Angina Who Undergo Percutaneous Coronary Intervention With Incomplete Revascularization"},{"nct_id":"NCT01088503","url":"https://clinicaltrials.gov/show/NCT01088503","official_title":"The TRANSLATE-ACS Study: Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome"},{"nct_id":"NCT01827319","url":"https://clinicaltrials.gov/show/NCT01827319","official_title":"A Multi-Center Single Arm Observational Registry of the Cardiogenesis Holmium: YAG Laser System Transmyocardial Revascularization for Angina Reduction"},{"nct_id":"NCT00808067","url":"https://clinicaltrials.gov/show/NCT00808067","official_title":"RELY-ABLE Long Term Multi-center Extension of Dabigatran Treatment in Patients With Atrial Fibrillation Who Completed the RE-LY Trial and a Cluster Randomised Trial to Assess the Effect of a Knowledge Translation Intervention on Patient Outcomes"},{"nct_id":"NCT01608100","url":"https://clinicaltrials.gov/show/NCT01608100","official_title":"Design Validation Protocol for the Evaluation of ARCHITECT STAT High Sensitive Troponin I Assay"},{"nct_id":"NCT01819597","url":"https://clinicaltrials.gov/show/NCT01819597","official_title":"EDAS (Surgical) Revascularization for Symptomatic Intracranial Arterial Stenosis"},{"nct_id":"NCT02173379","url":"https://clinicaltrials.gov/show/NCT02173379","official_title":"A Clinical Evaluation of Absorbâ¢ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions"},{"nct_id":"NCT01751906","url":"https://clinicaltrials.gov/show/NCT01751906","official_title":"A Clinical Evaluation of Absorbâ¢ BVS, the Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Subjects With de Novo Native Coronary Artery Lesions."},{"nct_id":"NCT00005487","url":"https://clinicaltrials.gov/show/NCT00005487","official_title":"Multi-Ethnic Study of Atherosclerosis (MESA)"},{"nct_id":"NCT02057653","url":"https://clinicaltrials.gov/show/NCT02057653","official_title":"Evaluation of Goal-Directed Intraoperative Hemodynamic Optimization Protocol"},{"nct_id":"NCT01500434","url":"https://clinicaltrials.gov/show/NCT01500434","official_title":"PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Elementâ¢) for the Treatment of up to Two De Novo Coronary Artery Lesions - Long Lesion Sub-trial"},{"nct_id":"NCT01991795","url":"https://clinicaltrials.gov/show/NCT01991795","official_title":"A Multinational, Randomised, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Ticagrelor Twice Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Stroke in Patients With Type 2 Diabetes Mellitus (THEMIS - Effect of Ticagrelor on Health Outcomes in Diabetes Mellitus Patients Intervention Study)"},{"nct_id":"NCT00094302","url":"https://clinicaltrials.gov/show/NCT00094302","official_title":"Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT)"},{"nct_id":"NCT01120379","url":"https://clinicaltrials.gov/show/NCT01120379","official_title":"XIENCE VÂ® Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study (XIENCE VÂ® USA Long Term Follow-up Cohort)"},{"nct_id":"NCT00500617","url":"https://clinicaltrials.gov/show/NCT00500617","official_title":"Identification of Gene Expression Patterns in Circulating Cells That Predict the Presence of Coronary Artery Disease"},{"nct_id":"NCT01205776","url":"https://clinicaltrials.gov/show/NCT01205776","official_title":"Evaluation of XIENCE PRIMEâ¢ Everolimus Eluting Stent System (EECSS) or XIENCE VÂ® EECSS or XIENCE Xpeditionâ¢ EECSS or XIENCE PRO EECSS Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization"},{"nct_id":"NCT01790152","url":"https://clinicaltrials.gov/show/NCT01790152","official_title":"Health Effects After Anthracycline and Radiation Therapy (HEART): Dexrazoxane and Prevention of Anthracycline-Related Cardiomyopathy"},{"nct_id":"NCT00403767","url":"https://clinicaltrials.gov/show/NCT00403767","official_title":"A Prospective, Randomized, Double-Blind, Parallel-Group, Multicenter, Non-inferiority Study Comparing the Efficacy and Safety of Rivaroxaban (BAY 59-7939) With Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation"},{"nct_id":"NCT00153062","url":"https://clinicaltrials.gov/show/NCT00153062","official_title":"PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes: A Double-blind, Active and Placebo Controlled Study of Aggrenox vs. Clopidogrel, With and Without Micardis"},{"nct_id":"NCT00222352","url":"https://clinicaltrials.gov/show/NCT00222352","official_title":"Diagnosis and Treatment of Acute Coronary Syndromes in the Emergency Department: The Impact of Rapid Bedside cTnI Testing on Outcomes"},{"nct_id":"NCT01574534","url":"https://clinicaltrials.gov/show/NCT01574534","official_title":"A Prospective, Randomized, Controlled, Open Label, Multicenter Trial to Test the Non-inferiority of Drug Eluting Balloon vs. Drug Eluting Stent Treatment in de Novo Stenoses of Small Native Vessels Regarding Efficacy and Safety"},{"nct_id":"NCT00359801","url":"https://clinicaltrials.gov/show/NCT00359801","official_title":"An International, Multicenter, Large Simple Trial To Evaluate The Long-Term Pulmonary And Cardiovascular Safety Of Exubera In Patients With Diabetes Mellitus"},{"nct_id":"NCT01729871","url":"https://clinicaltrials.gov/show/NCT01729871","official_title":"A Randomized, Open-label, Active-controlled Multi-center Study to Assess Safety of Uninterrupted Rivaroxaban vs. Usual Care in Subjects Undergoing Catheter Ablation Therapy for Atrial Fibrillation"},{"nct_id":"NCT00157248","url":"https://clinicaltrials.gov/show/NCT00157248","official_title":"Long-term, Open-label Follow-up Treatment of Patients With Atrial Fibrillation Who Have Been Previously Treated With BIBR 1048 in the PETRO Trial (Trial 1160.20 - NCT01227629). (PETRO Extension Trial: PETRO-Ex)"},{"nct_id":"NCT01683448","url":"https://clinicaltrials.gov/show/NCT01683448","official_title":"The Effect of Perioperative Medications on the Outcomes of Patients Undergoing Cardiac Surgery"},{"nct_id":"NCT00316108","url":"https://clinicaltrials.gov/show/NCT00316108","official_title":"Boston Scientific EPI: A Carotid Stenting Trial for High-Risk Surgical Patients"},{"nct_id":"NCT00590980","url":"https://clinicaltrials.gov/show/NCT00590980","official_title":"The Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Study"},{"nct_id":"NCT00082121","url":"https://clinicaltrials.gov/show/NCT00082121"},{"nct_id":"NCT01989195","url":"https://clinicaltrials.gov/show/NCT01989195","official_title":"Efficacy of EVP 1001-1 (SeeMore) in the Assessment of Myocardial Viability in Patients With Cardiovascular Disease"},{"nct_id":"NCT02389946","url":"https://clinicaltrials.gov/show/NCT02389946","official_title":"BIOTRONIK - A Prospective Randomized Multicenter Study to Assess the SaFety and Effectiveness of the Orsiro SiroLimus Eluting Coronary Stent System in the Treatment Of Subjects With up to Three De Novo or Restenotic Coronary Artery Lesions - V"},{"nct_id":"NCT00239681","url":"https://clinicaltrials.gov/show/NCT00239681","official_title":"A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTORÂ®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein"},{"nct_id":"NCT02105246","url":"https://clinicaltrials.gov/show/NCT02105246","official_title":"The Healthy Heart Study"},{"nct_id":"NCT00722748","url":"https://clinicaltrials.gov/show/NCT00722748","official_title":"The Genebank at Scripps Clinic Registry"},{"nct_id":"NCT00682526","url":"https://clinicaltrials.gov/show/NCT00682526","official_title":"Pre-hospital Wireless Transmission of Electrocardiograms to a Cardiologist Via a Hand-held Device: The TIME Multicenter Study"},{"nct_id":"NCT00106938","url":"https://clinicaltrials.gov/show/NCT00106938","official_title":"Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I)"},{"nct_id":"NCT01137513","url":"https://clinicaltrials.gov/show/NCT01137513","official_title":"T-Wave Alternans in Patients Acute Coronary Syndrome"},{"nct_id":"NCT02064439","url":"https://clinicaltrials.gov/show/NCT02064439","official_title":"Reduced-dosed Rivaroxaban and Standard-dosed Rivaroxaban Versus ASA in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis and/or Pulmonary Embolism"},{"nct_id":"NCT00600327","url":"https://clinicaltrials.gov/show/NCT00600327","official_title":"Carotid Artery Revascularization Using the Boston Scientific EPI Filter Wire EZâ¢ and the EndoTexâ¢ NexStentâ¢"},{"nct_id":"NCT00327691","url":"https://clinicaltrials.gov/show/NCT00327691","official_title":"The Effect Of LDL-Cholesterol, Lowering Beyond Currently Recommended Minimum Targets On Coronary Heart Disesse (CHD) Recurrence In Patients With Pre-Existing CHD"},{"nct_id":"NCT01114269","url":"https://clinicaltrials.gov/show/NCT01114269","official_title":"PRE-DETERMINE: Biologic Markers and MRI SCD Cohort Study"},{"nct_id":"NCT01858532","url":"https://clinicaltrials.gov/show/NCT01858532","official_title":"A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects With Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy With Atrasentan"},{"nct_id":"NCT00676520","url":"https://clinicaltrials.gov/show/NCT00676520","official_title":"XIENCE VÂ® Everolimus Eluting Coronary Stent System (EECSS) USA Post-Approval Study"},{"nct_id":"NCT00307047","url":"https://clinicaltrials.gov/show/NCT00307047","official_title":"SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE VÂ® Everolimus Eluting Coronary Stent System in the Treatment of Subjects With de Novo Native Coronary Artery Lesions"},{"nct_id":"NCT01515813","url":"https://clinicaltrials.gov/show/NCT01515813","official_title":"A Randomized Controlled Trial to Compare the Effects of Highly Active Antiretroviral Therapy (HAART) Versus Statin Therapy on Endothelial Function and Markers of Inflammation/Coagulation In HIV-Infected Individuals With High CD4 Cell Counts"},{"nct_id":"NCT01042769","url":"https://clinicaltrials.gov/show/NCT01042769","official_title":"A Safety and Efficacy Study to Evaluate the Potential of Aleglitazar to Reduce Cardiovascular Risk in Coronary Heart Disease (CHD) Patients With a Recent Acute Coronary Syndrome (ACS) Event and Type 2 Diabetes Mellitus (T2D)"},{"nct_id":"NCT02240810","url":"https://clinicaltrials.gov/show/NCT02240810","official_title":"PLATINUM Diversity: Outcomes With the Promus PREMIERâ¢ Stent in Women and Minorities (S2326)"},{"nct_id":"NCT01720446","url":"https://clinicaltrials.gov/show/NCT01720446","official_title":"A Long-term, Randomised, Double-blind, Placebo-controlled, Multinational, Multi-centre Trial to Evaluate Cardiovascular and Other Long-term Outcomes With Semaglutide in Subjects With Type 2 Diabetes (SUSTAINâ¢ 6 - Long-term Outcomes)"},{"nct_id":"NCT00619775","url":"https://clinicaltrials.gov/show/NCT00619775","official_title":"Carotid Revascularization With ev3 Arterial Technology Evolution (CREATE) Trial"},{"nct_id":"NCT01422889","url":"https://clinicaltrials.gov/show/NCT01422889","official_title":"A U.S. Post-Approval Study of the IONâ¢ Paclitaxel-Eluting Platinum Chromium Coronary Stent System"},{"nct_id":"NCT01959529","url":"https://clinicaltrials.gov/show/NCT01959529","official_title":"A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events"},{"nct_id":"NCT01032629","url":"https://clinicaltrials.gov/show/NCT01032629","official_title":"A Randomized, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of JNJ-28431754 on Cardiovascular Outcomes in Adult Subjects With Type 2 Diabetes Mellitus"},{"nct_id":"NCT01331837","url":"https://clinicaltrials.gov/show/NCT01331837","official_title":"A Clinical Outcomes Study to Evaluate the Effects of IL-6 Receptor Blockade With Tocilizumab (TCZ) in Comparison With Etanercept (ETA) on the Rate of Cardiovascular Events in Patients With Moderate to Severe Rheumatoid Arthritis (RA)"},{"nct_id":"NCT02545049","url":"https://clinicaltrials.gov/show/NCT02545049","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate Efficacy and Safety of Finerenone on the Reduction of Cardiovascular Morbidity and Mortality in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease in Addition to Standard of Care."},{"nct_id":"NCT01687998","url":"https://clinicaltrials.gov/show/NCT01687998","official_title":"Assessment of Clinical Effects of Cholesteryl Ester Transfer Protein Inhibition With Evacetrapib in Patients at a High-Risk for Vascular Outcomes"},{"nct_id":"NCT01715818","url":"https://clinicaltrials.gov/show/NCT01715818","official_title":"A PHASE 3B STUDY TO EVALUATE THE POTENTIAL OF ALEGLITAZAR TO REDUCE CARDIOVASCULAR RISK IN PATIENTS WITH STABLE CARDIOVASCULAR DISEASE AND GLUCOSE ABNORMALITIES"},{"nct_id":"NCT02276547","url":"https://clinicaltrials.gov/show/NCT02276547","official_title":"Early Feasibility Study of the Neovasc Tiaraâ¢ Mitral Transcatheter Heart Valve With the Tiaraâ¢ Transapical Delivery System"},{"nct_id":"NCT02293603","url":"https://clinicaltrials.gov/show/NCT02293603","official_title":"A Randomized, Double-blind, Placebo-controlled, Phase I Study of the Safety of Multi-vessel Intra-coronary Delivery of Allogeneic Human Cardiosphere-Derived Stem Cells in Patients With Dilated Cardiomyopathy (DCM)"},{"nct_id":"NCT01850082","url":"https://clinicaltrials.gov/show/NCT01850082","official_title":"CSP #588 - Randomized Endo-Vein Graft Prospective (REGROUP) Trial"},{"nct_id":"NCT02313909","url":"https://clinicaltrials.gov/show/NCT02313909","official_title":"Multicenter, Randomized, Double-blind, Double-dummy, Active-comparator, Event-driven, Superiority Phase III Study of Secondary Prevention of Stroke and Prevention of Systemic Embolism in Patients With a Recent Embolic Stroke of Undetermined Source (ESUS), Comparing Rivaroxaban 15 mg Once Daily With Aspirin 100 mg"},{"nct_id":"NCT00576693","url":"https://clinicaltrials.gov/show/NCT00576693","official_title":"Stenting vs. Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis"},{"nct_id":"NCT01435031","url":"https://clinicaltrials.gov/show/NCT01435031","official_title":"Evaluation of the XIENCE PRIMEâ¢ LL and XIENCE Nanoâ¢ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total Occlusions"},{"nct_id":"NCT00395785","url":"https://clinicaltrials.gov/show/NCT00395785","official_title":"Protection During Carotid Stenting in High Risk Patients With the TriActiv ProGuard System"},{"nct_id":"NCT00963781","url":"https://clinicaltrials.gov/show/NCT00963781","official_title":"A Clinical Evaluation of Dual Antiplatelet Therapy Duration Following Treatment With the Medtronic Endeavor Zotarolimus-eluting Coronary Stent"},{"nct_id":"NCT00032370","url":"https://clinicaltrials.gov/show/NCT00032370","official_title":"CSP #411 - The Coronary Artery Revascularization Prophylaxis (CARP) Trial"},{"nct_id":"NCT00822900","url":"https://clinicaltrials.gov/show/NCT00822900","official_title":"Phase 3 Clinical Trial to Determine if Progesterone Along With Standard Medical Care for Brain Injury is More Effective at Limiting the Amount of Damage Cause by a Traumatic Brain Injury Than Standard Medical Care Alone."},{"nct_id":"NCT01259856","url":"https://clinicaltrials.gov/show/NCT01259856","official_title":"Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea Therapy in the Treatment of High Risk Polycythemia Vera (PV) and High Risk Essential Thrombocythemia (ET)"},{"nct_id":"NCT00503698","url":"https://clinicaltrials.gov/show/NCT00503698","official_title":"Efficacy and Safety of Somatropin in Adult Patients on Chronic Haemodialysis"},{"nct_id":"NCT00251849","url":"https://clinicaltrials.gov/show/NCT00251849","official_title":"Prospective Evaluation of Rifalazil Effect On Vascular Symptoms of Intermittent Claudication and Other Endpoints in Chlamydia Seropositive Patients"},{"nct_id":"NCT00457002","url":"https://clinicaltrials.gov/show/NCT00457002","official_title":"A Phase 3 Randomized, Double-Blind, Parallel-group, Multi-center Study of the Safety and Efficacy of Apixaban for Prophylaxis of Venous Thromboembolism in Acutely Ill Medical Subjects During and Following Hospitalization."},{"nct_id":"NCT01249027","url":"https://clinicaltrials.gov/show/NCT01249027","official_title":"XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study"},{"nct_id":"NCT00916370","url":"https://clinicaltrials.gov/show/NCT00916370","official_title":"SPIRIT PRIME Clinical Trial."},{"nct_id":"NCT00200629","url":"https://clinicaltrials.gov/show/NCT00200629","official_title":"A Pilot Study Examining the Value of Combined Exercise and Adenosine Stress Myocardial Perfusion Imaging as Compared With Adenosine Testing Alone for the Evaluation of Women at Intermediate or High Likelihood for Coronary Artery Disease"},{"nct_id":"NCT01498692","url":"https://clinicaltrials.gov/show/NCT01498692","official_title":"PLATINUM: A Prospective, Randomized, Multicenter Trial to Assess an Everolimus-Eluting Coronary Stent System (PROMUS Elementâ¢) for the Treatment of up to Two De Novo Coronary Artery Lesions - Small Vessel Sub-trial"},{"nct_id":"NCT01396525","url":"https://clinicaltrials.gov/show/NCT01396525","official_title":"A Prospective, Non-randomized, Two Arm, Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Proâ¢ Peripheral Self-Expanding Stent System and the Omnilink Eliteâ¢ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery."},{"nct_id":"NCT00844532","url":"https://clinicaltrials.gov/show/NCT00844532","official_title":"A Prospective, Non-randomized, 2 Arm (AP Arm & Omni-Link Elite [OE] Arm-separately Posted as: NCT01396525), Multi-center Clinical Trial to Evaluate the Safety and Efficacy of the Absolute Proâ¢ Peripheral Self-Expanding Stent System and the Omnilink Eliteâ¢ Peripheral Balloon-Expandable Stent System in Subjects With Atherosclerotic de Novo or Restenotic Lesions in the Native Common Iliac Artery and/or Native External Iliac Artery. CAUTION: The Omnilink Eliteâ¢ Peripheral Balloon-expandable Stent System is an Investigational Device. Limited by Federal (U.S.) Law to Investigational Use Only."},{"nct_id":"NCT00282711","url":"https://clinicaltrials.gov/show/NCT00282711","official_title":"The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?\"A Multi-Center, Prospective, Randomized Study to Establish the Optimal Method for Detection of CAD Risk in Women at an Intermediate-High Pre-Test Likelihood CAD\""},{"nct_id":"NCT00095238","url":"https://clinicaltrials.gov/show/NCT00095238","official_title":"Irbesartan in Heart Failure With Preserved Systolic Function (I-Preserve)"},{"nct_id":"NCT01144338","url":"https://clinicaltrials.gov/show/NCT01144338","official_title":"Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL). A Randomized, Placebo Controlled Clinical Trial to Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus."},{"nct_id":"NCT00133731","url":"https://clinicaltrials.gov/show/NCT00133731","official_title":"A Multinational, Randomized, Double-Blind, Double-Dummy, Exploratory, Parallel Group, Dose-Ranging Phase II Study to Evaluate Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Several Intravenous Regimens of Factor Xa Inhibitor Otamixaban (XRP0673), in Comparison to Intravenous Unfractionated Heparin, in Subjects Undergoing Non-Urgent Percutaneous Coronary Intervention"},{"nct_id":"NCT01090310","url":"https://clinicaltrials.gov/show/NCT01090310","official_title":"A 38-week Extension to a 24-week Multicenter, Randomized, Double-masked, Placebo Controlled, Dose-ranging Phase III Study of AIN457 Versus Placebo for Maintaining Uveitis Suppression When Reducing Systemic Immunosuppression in Patients With Quiescent, Non-infectious Intermediate, Posterior or Panuveitis"},{"nct_id":"NCT02014701","url":"https://clinicaltrials.gov/show/NCT02014701","official_title":"Incremental Utility of Myocardial Contrast Echocardiography for the Assessment of the Infarct Related Artery and Risk Area in Patients With Non-ST Segment Elevation Myocardial Infarction."},{"nct_id":"NCT01994720","url":"https://clinicaltrials.gov/show/NCT01994720","official_title":"A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events With Ticagrelor Compared to Aspirin (ASA) in Patients With Acute Ischaemic Stroke or TIA."},{"nct_id":"NCT02620397","url":"https://clinicaltrials.gov/show/NCT02620397","official_title":"Clinical Study to Validate the Use of a New Point of Care Troponin I Test as an Aid in the Diagnosis of Myocardial Infarction and Prognosis of Subjects Presenting With Symptoms of Acute Coronary Syndrome"},{"nct_id":"NCT02111564","url":"https://clinicaltrials.gov/show/NCT02111564","official_title":"Medically Ill Patient Assessment of Rivaroxaban Versus Placebo in Reducing Post-Discharge Venous Thrombo-Embolism Risk"},{"nct_id":"NCT01923740","url":"https://clinicaltrials.gov/show/NCT01923740","official_title":"A Clinical Evaluation of Absorbâ¢ BVS, the Bioresorbable Vascular Scaffold, in the Treatment of Subjects With de Novo Native Coronary Artery Lesions in Chinese Population"},{"nct_id":"NCT02239120","url":"https://clinicaltrials.gov/show/NCT02239120","official_title":"Randomized, Double-blind, Evaluation in Secondary Stroke Prevention Comparing the EfficaCy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, Oral b.i.d.) Versus Acetylsalicylic Acid (100 mg Oral q.d.) in Patients With Embolic Stroke of Undetermined Source (RESPECT ESUS)"},{"nct_id":"NCT00580216","url":"https://clinicaltrials.gov/show/NCT00580216","official_title":"A Multicenter, Randomized, Double-blind, Assessor-blind, Non-inferiority Study Comparing the Efficacy and Safety of Once-weekly Subcutaneous Biotinylated Idraparinux (SSR126517E) With Oral Adjusted-dose Warfarin in the Prevention of Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation"},{"nct_id":"NCT00439725","url":"https://clinicaltrials.gov/show/NCT00439725","official_title":"Once-daily Oral Direct Factor Xa Inhibitor Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic Venous Thromboembolism in Patients With Symptomatic Deep-vein Thrombosis or Pulmonary Embolism. The Einstein-Extension Study"},{"nct_id":"NCT01830543","url":"https://clinicaltrials.gov/show/NCT01830543","official_title":"An Open-label, Randomized, Controlled, Multicenter Study Exploring Two Treatment Strategies of Rivaroxaban and a Dose-Adjusted Oral Vitamin K Antagonist Treatment Strategy in Subjects With Atrial Fibrillation Who Undergo Percutaneous Coronary Intervention"},{"nct_id":"NCT01663402","url":"https://clinicaltrials.gov/show/NCT01663402","official_title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Effect of Alirocumab (SAR236553/REGN727) on the Occurrence of Cardiovascular Events in Patients Who Have Recently Experienced an Acute Coronary Syndrome"},{"nct_id":"NCT02540993","url":"https://clinicaltrials.gov/show/NCT02540993","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter, Event-driven Phase 3 Study to Investigate the Safety and Efficacy of Finerenone, in Addition to Standard of Care, on the Progression of Kidney Disease in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease"},{"nct_id":"NCT01920711","url":"https://clinicaltrials.gov/show/NCT01920711","official_title":"A Multicenter, Randomized, Double-blind, Parallel Group, Active-controlled Study to Evaluate the Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients (NYHA Class II-IV) With Preserved Ejection Fraction"},{"nct_id":"NCT01147250","url":"https://clinicaltrials.gov/show/NCT01147250","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, Multicenter Study to Evaluate Cardiovascular Outcomes During Treatment With Lixisenatide in Type 2 Diabetic Patients After an Acute Coronary Syndrome"},{"nct_id":"NCT00423319","url":"https://clinicaltrials.gov/show/NCT00423319","official_title":"A Phase 3 Randomized, Double-blind, Active-controlled, Parallel-group, Multi-center Study to Evaluate the Safety and Efficacy of Apixaban in Subjects Undergoing Elective Total Hip Replacement Surgery (The Advance-3 Study Apixaban Dosed Orally Versus Anticoagulation With Injectable Enoxaparin to Prevent Venous Thromboembolism)"},{"nct_id":"NCT02104817","url":"https://clinicaltrials.gov/show/NCT02104817","official_title":"A Long-Term Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh Cardiovascular Risk PatienTs With Hypertriglyceridemia (STRENGTH)"},{"nct_id":"NCT00501059","url":"https://clinicaltrials.gov/show/NCT00501059","official_title":"A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Assess the Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease"},{"nct_id":"NCT00550459","url":"https://clinicaltrials.gov/show/NCT00550459","official_title":"A Pilot, Phase 3B, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study of the Effects of Titrated Oral Tolvaptan 15, 30, or 60 mg QD on Cognitive and Neurological Function in Elderly Hyponatremic Patients"},{"nct_id":"NCT01938248","url":"https://clinicaltrials.gov/show/NCT01938248","official_title":"Apixaban for the Reduction of Thrombo-Embolism in Patients With Device-Detected Sub-Clinical Atrial Fibrillation"},{"nct_id":"NCT00489541","url":"https://clinicaltrials.gov/show/NCT00489541","official_title":"A Prospective Evaluation in a Non-Randomized Trial of the Safety and Efficacy of the Use of the TAXUSÂ® ElementTM Paclitaxel-Eluting Coronary Stent System for the Treatment of De Novo Coronary Artery Lesions in Small Vessels"},{"nct_id":"NCT00032435","url":"https://clinicaltrials.gov/show/NCT00032435","official_title":"CSP #453 - Homocysteinemia in Kidney and Endstage Renal Disease Study (HOST)"},{"nct_id":"NCT01054560","url":"https://clinicaltrials.gov/show/NCT01054560","official_title":"SOLITAIREâ¢ FR With the Intention For Thrombectomy (SWIFT) Study"},{"nct_id":"NCT01764451","url":"https://clinicaltrials.gov/show/NCT01764451","official_title":"Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins"},{"nct_id":"NCT01934725","url":"https://clinicaltrials.gov/show/NCT01934725","official_title":"Searching for Explanations for Cryptogenic Stroke in the Young: Revealing the Etiology, Triggers, and Outcome (SECRETO)"},{"nct_id":"NCT01496209","url":"https://clinicaltrials.gov/show/NCT01496209"},{"nct_id":"NCT01406808","url":"https://clinicaltrials.gov/show/NCT01406808","official_title":"A Pilot Randomized Trial of Personal Genomics for Preventive Cardiology"},{"nct_id":"NCT00932958","url":"https://clinicaltrials.gov/show/NCT00932958","official_title":"Physicians International CCTA Utilization Registry"},{"nct_id":"NCT00270985","url":"https://clinicaltrials.gov/show/NCT00270985","official_title":"The Metabolic Effects of Almond Consumption in Adults With Pre-Diabetes"},{"nct_id":"NCT00466713","url":"https://clinicaltrials.gov/show/NCT00466713","official_title":"Defining the Role of Insulin Resistance in 'Idiopathic' Dilated Cardiomyopathy"},{"nct_id":"NCT01383382","url":"https://clinicaltrials.gov/show/NCT01383382","official_title":"Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool"},{"nct_id":"NCT02663908","url":"https://clinicaltrials.gov/show/NCT02663908","official_title":"A Multi-Center, Randomized, Assessor-Blind, Controlled Trial Comparing the Occurrence of Major Adverse Cardiovascular Events (MACEs) in Patients With Prostate Cancer and Cardiovascular Disease Receiving Degarelix (Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist) or Leuprolide (GnRH Receptor Agonist)"},{"nct_id":"NCT02148341","url":"https://clinicaltrials.gov/show/NCT02148341","official_title":"Implementation of the Hospital to Home (H2H) Heart Failure Initiative"},{"nct_id":"NCT00657280","url":"https://clinicaltrials.gov/show/NCT00657280","official_title":"Effect of Sitagliptin on Insulin Resistance and Myocardial Metabolism in Heart Failure"},{"nct_id":"NCT01765270","url":"https://clinicaltrials.gov/show/NCT01765270","official_title":"Mechanistic Assessment of the Properties of Saxagliptin in Subjects Undergoing Coronary Artery Bypass Graft Surgery: a Randomized, Double-Blind, Placebo-Controlled Clinical Trial"},{"nct_id":"NCT00032357","url":"https://clinicaltrials.gov/show/NCT00032357","official_title":"CSP #410 - The Iron (Fe) and Atherosclerosis Study (FeAST)"},{"nct_id":"NCT00626457","url":"https://clinicaltrials.gov/show/NCT00626457","official_title":"Promoting Healthy Weight With 'Stability Skills First' (Fresh Start Weight Loss Study)"},{"nct_id":"NCT02641496","url":"https://clinicaltrials.gov/show/NCT02641496","official_title":"Cognitive Behavioral Therapy to Increase CPAP Adherence in Veterans With PTSD"},{"nct_id":"NCT00572949","url":"https://clinicaltrials.gov/show/NCT00572949","official_title":"Magnetocardiography (MCG) in the Diagnosis of Chest Pain Syndrome"},{"nct_id":"NCT01685567","url":"https://clinicaltrials.gov/show/NCT01685567","official_title":"INVESTIGATION of FLOW ALTERED, SHORT TRANSCERVICAL CAROTID ARTERY STENTING in PATIENTS With SIGNIFICANT CAROTID ARTERY DISEASE With Filter."},{"nct_id":"NCT01928927","url":"https://clinicaltrials.gov/show/NCT01928927","official_title":"Effects of Telmisartan on Fibrotic and Inflammatory Contributors to End-Organ Disease in HIV-Infected Patients Well Controlled on Antiretroviral Therapy"},{"nct_id":"NCT00714623","url":"https://clinicaltrials.gov/show/NCT00714623","official_title":"A Prospective Registry for the Use of CypherTM Sirolimus-Eluting Stents In Patients With Coronary Artery Disease Treated With Percutaneous Coronary Interventions at Scripps Clinic"},{"nct_id":"NCT00489164","url":"https://clinicaltrials.gov/show/NCT00489164","official_title":"A Randomized Feasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery Lesions (DECODE)"},{"nct_id":"NCT00076141","url":"https://clinicaltrials.gov/show/NCT00076141","official_title":"CSP #499A - Selenium and Vitamin E Cancer Prevention Trial - COHORT"},{"nct_id":"NCT01524705","url":"https://clinicaltrials.gov/show/NCT01524705","official_title":"FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR"},{"nct_id":"NCT00570024","url":"https://clinicaltrials.gov/show/NCT00570024","official_title":"The Effects of Traditional Acupuncture on Mechanisms of Coronary Heart Disease"},{"nct_id":"NCT00180492","url":"https://clinicaltrials.gov/show/NCT00180492","official_title":"Carotid RX ACCULINK(TM)/ACCUNET(TM) Post-Approval Trial to Uncover Unanticipated or Rare Events - CAPTURE"},{"nct_id":"NCT01259817","url":"https://clinicaltrials.gov/show/NCT01259817","official_title":"Single Arm Salvage Therapy With Pegylated Interferon Alfa-2a for Patients With High Risk Polycythemia Vera or High Risk Essential Thrombocythemia Who Are Either Hydroxyurea Resistant or Intolerant or Have Had Abdominal Vein Thrombosis"},{"nct_id":"NCT00287586","url":"https://clinicaltrials.gov/show/NCT00287586","official_title":"Effects of Testosterone Replacement on Atherosclerosis Progression in Older Men With Low Testosterone Levels"},{"nct_id":"NCT00460187","url":"https://clinicaltrials.gov/show/NCT00460187","official_title":"Evaluating the Use of the FiberNet Embolic Protection System in Carotid Artery Stenting: The EPIC US Pivotal Study."},{"nct_id":"NCT00346515","url":"https://clinicaltrials.gov/show/NCT00346515","official_title":"Evaluating the Use of the FiberNetÂ® Emboli Protection Device in Carotid Artery Stenting: The EPIC US Feasibility Study"},{"nct_id":"NCT01419171","url":"https://clinicaltrials.gov/show/NCT01419171","official_title":"OMEGA: A Prospective, Multicenter Single-Arm Trial to Assess the OMEGAâ¢ Coronary Stent System for the Treatment of a Single De Novo Coronary Artery Lesion"},{"nct_id":"NCT02648347","url":"https://clinicaltrials.gov/show/NCT02648347","official_title":"Phase 3, Randomized, Open-Label, Active-Controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Correction of Anemia in Subjects With Non-Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CORRECTION)"},{"nct_id":"NCT00518284","url":"https://clinicaltrials.gov/show/NCT00518284","official_title":"A Phase II Trial of ABI-007 (Paclitaxel Albumin-bound Particles) for the Prevention of Restenosis Following Revascularization of the Superficial Femoral Artery (SFA)"},{"nct_id":"NCT00499902","url":"https://clinicaltrials.gov/show/NCT00499902","official_title":"Phase 2, Multicenter, Open-Label, Two-Stage Study to Evaluate the Safety and Efficacy of Intra-Arterial Catheter-Directed Alfimeprase for Restoration of Neurologic Function and Rapid Opening of Arteries in Stroke (CARNEROS-1)"},{"nct_id":"NCT00653601","url":"https://clinicaltrials.gov/show/NCT00653601","official_title":"Bridging Therapy in Patients at High Risk for Stent Thrombosis Undergoing Surgery"},{"nct_id":"NCT00231244","url":"https://clinicaltrials.gov/show/NCT00231244","official_title":"Sirolimus-Eluting BX VELOCITYTM Balloon-Expandable Stent in a Compassionate Use Registry"},{"nct_id":"NCT01227629","url":"https://clinicaltrials.gov/show/NCT01227629","official_title":"Dose Exploration in Patients With Atrial Fibrillation"},{"nct_id":"NCT01470599","url":"https://clinicaltrials.gov/show/NCT01470599","official_title":"A Open-label Extension Study Of Cp-690,550 As Maintenance Therapy In Patients With Crohn's Disease"},{"nct_id":"NCT01910389","url":"https://clinicaltrials.gov/show/NCT01910389","official_title":"Phosphodiesterase Type 5 Inhibition With Tadalafil Changes Outcomes in Heart Failure"},{"nct_id":"NCT00371683","url":"https://clinicaltrials.gov/show/NCT00371683","official_title":"A Phase 3 Randomized, Double-Blind Active-Controlled (Enoxaparin), Parallel-Group, Multi-Center Study to Evaluate the Safety and Efficacy of Oral Apixaban in Subjects Undergoing Elective Total Knee Replacement Surgery"},{"nct_id":"NCT00673985","url":"https://clinicaltrials.gov/show/NCT00673985","official_title":"A Randomized Study Comparing the Edwards Self-ExpandIng LifeStent Versus Angioplasty-alone In LEsions INvolving The SFA and/or Proximal Popliteal Arter"},{"nct_id":"NCT02392351","url":"https://clinicaltrials.gov/show/NCT02392351","official_title":"A Boston Scientific Clinical Trial of Renal Denervation Using the Vessix Reduceâ¢ Catheter and Vessixâ¢ Generator for the Treatment of HyperTensioN: REINFORCE"},{"nct_id":"NCT02508454","url":"https://clinicaltrials.gov/show/NCT02508454","official_title":"The Miami Heart Study at Baptist Health South Florida: A Prospective Study of Sub-Clinical Cardiovascular Disease and Emerging Cardiovascular Risk Factors in Asymptomatic Young & Middle-Aged Adults"},{"nct_id":"NCT02415803","url":"https://clinicaltrials.gov/show/NCT02415803","official_title":"Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With Non-ST-Elevation Acute Coronary Syndrome: A Randomized Clinical Trial"},{"nct_id":"NCT02419521","url":"https://clinicaltrials.gov/show/NCT02419521","official_title":"A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting Stent System Medtronic Resolute Onyx Core (2.25 mm - 4.0 mm) Clinical Study"},{"nct_id":"NCT02412501","url":"https://clinicaltrials.gov/show/NCT02412501","official_title":"A Clinical Evaluation of the Medtronic Resolute Onyx Zotarolimus-Eluting 2.0 mm Stent Resolute Onyx 2.0 mm Clinical Study"},{"nct_id":"NCT00124891","url":"https://clinicaltrials.gov/show/NCT00124891","official_title":"Study Evaluating Subjects With Non-Sustained Ventricular Tachycardia"},{"nct_id":"NCT02524834","url":"https://clinicaltrials.gov/show/NCT02524834","official_title":"Proposed Single Center Investigational Device Exemption: Endovascular Repair of Descending ThoracoAbdominal Aortic Pathologies Using Physician Modified Endovascular Prosthesis"},{"nct_id":"NCT01218828","url":"https://clinicaltrials.gov/show/NCT01218828","official_title":"Hydration With Different Sodium Chloride Protocols for the Prevention of Contrast Medium-induced Nephropathy in Patients Undergoing Coronary Angiography: a Randomized Trial"},{"nct_id":"NCT01913483","url":"https://clinicaltrials.gov/show/NCT01913483","official_title":"ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial"},{"nct_id":"NCT02163408","url":"https://clinicaltrials.gov/show/NCT02163408","official_title":"3D Multi-Contrast Atherosclerosis Characterization of the Carotid Artery"},{"nct_id":"NCT01920594","url":"https://clinicaltrials.gov/show/NCT01920594","official_title":"A Phase II, Randomized, Placebo-Controlled, Double-Blind (Sponsor Open) Study of GSK1278863, a HIF-Prolyl Hydroxylase Inhibitor, to Reduce Ischemic Events in Patients Undergoing Thoracic Aortic Aneurysm Repair"},{"nct_id":"NCT00116428","url":"https://clinicaltrials.gov/show/NCT00116428","official_title":"NAVISTARÂ® THERMOCOOLÂ® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation"},{"nct_id":"NCT01418196","url":"https://clinicaltrials.gov/show/NCT01418196","official_title":"Relation of Diet to Heart Disease Risk Factors in Children"},{"nct_id":"NCT00418171","url":"https://clinicaltrials.gov/show/NCT00418171","official_title":"An International, Multicenter, Large Simple Trial (LST) To Compare The Cardiovascular Safety Of Ziprasidone And Olanzapine"},{"nct_id":"NCT02019264","url":"https://clinicaltrials.gov/show/NCT02019264","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors"},{"nct_id":"NCT01662908","url":"https://clinicaltrials.gov/show/NCT01662908","official_title":"A Randomized, Open-Label, Parallel-Group, Multi-Center Study for the Evaluation of Efficacy and Safety of Edoxaban Monotherapy Versus (LMW) Heparin/Warfarin in Subjects With Symptomatic Deep-Vein Thrombosis - Edoxaban Thrombus Reduction Imaging Study"},{"nct_id":"NCT02588690","url":"https://clinicaltrials.gov/show/NCT02588690","official_title":"Beauty From Within Community Screening Project"},{"nct_id":"NCT02265250","url":"https://clinicaltrials.gov/show/NCT02265250","official_title":"Magnetic Resonance Imaging for Global Atherosclerosis Risk Assessment Pilot Study"},{"nct_id":"NCT02582021","url":"https://clinicaltrials.gov/show/NCT02582021","official_title":"Women's Ischemia Syndrome Evaluation (WISE) - Coronary Microvascular Dysfunction (CMD) and Heart Failure With Preserved Ejection Fraction (HFpEF)"},{"nct_id":"NCT00252525","url":"https://clinicaltrials.gov/show/NCT00252525","official_title":"CSP #465B - Correlation of Plasma Endothelial Cell (Basic Fibroblast Growth Factor) Activity With Cardiovascular Events In Patients With Diabetes Mellitus Type 2"},{"nct_id":"NCT01856504","url":"https://clinicaltrials.gov/show/NCT01856504","official_title":"Validation of an Intracycle CT Motion CORrection Algorithm for Diagnostic AccuracY: A Prospective Multicenter Study"},{"nct_id":"NCT00144339","url":"https://clinicaltrials.gov/show/NCT00144339","official_title":"A Randomized, Double-blind, Placebo-controlled, Parallel Group Trial Assessing the Rate of Decline of Lung Function With Tiotropium 18 mcg Inhalation Capsule Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)."}]